miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma

Pleiotropic Action of Renal Cell Carcinoma-Dysregulated miRNAs on Hypoxia-Related Signaling Pathways

(2012) Zsuzsanna Lichner et al.   AMERICAN JOURNAL OF PATHOLOGY

miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms

(2012) U. Senanayake et al.   CARCINOGENESIS

Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients

(2012) Abeer A. Bahnassy et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer

(2012) Xiao-Feng Le et al.   PLoS One

Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases

(2011) Zofia Wotschofsky et al.   ANALYTICAL BIOCHEMISTRY

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma

(2011) Danielle M. Patterson et al.   ANGIOGENESIS

MicroRNAs and their target gene networks in renal cell carcinoma

(2011) Martina Redova et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy

(2011) Aidan P. Noon et al.   BJU INTERNATIONAL

Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network

(2011) Jin Wang et al.   BMC Systems Biology

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

(2011) N M A White et al.   BRITISH JOURNAL OF CANCER

MicroRNAs as new therapeutic targets and tools in cancer

(2011) Paolo Gandellini et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Translating Molecular Signatures of Renal Cell Carcinoma into Clinical Practice

(2011) Nicole M.A. White et al.   JOURNAL OF UROLOGY

miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation

(2011) Nicole M.A. White et al.   JOURNAL OF UROLOGY

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

(2011) Peixin Dong et al.   Molecular Cancer

Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma

(2011) Rit Vatsyayan et al.   MOLECULAR CARCINOGENESIS

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses

(2011) Heba W. Z. Khella et al.   TUMOR BIOLOGY

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

(2011) Joana Heinzelmann et al.   WORLD JOURNAL OF UROLOGY

Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs

(2010) Nicole M. White et al.   BIOLOGICAL CHEMISTRY

MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer

(2010) Nicole MA White et al.   BMC Medicine

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer

(2010) N M A White et al.   BRITISH JOURNAL OF CANCER

p53 and MDM2 in renal cell carcinoma

(2010) Aidan P. Noon et al.   CANCER

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development

(2010) Flavia Pichiorri et al.   CANCER CELL

MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism

(2010) Radosław Polański et al.   FEBS LETTERS

miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice

(2010) Zhipeng Meng et al.   HEPATOLOGY

miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation

(2010) Valentina Boni et al.   MOLECULAR CANCER THERAPEUTICS

Metastamirs: a stepping stone towards improved cancer management

(2010) Nicole M. A. White et al.   Nature Reviews Clinical Oncology

Epidemiology and risk factors for kidney cancer

(2010) Wong-Ho Chow et al.   Nature Reviews Urology

MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?

(2010) Monirath Hav et al.   VIRCHOWS ARCHIV

Clustered microRNAs' coordination in regulating protein-protein interaction network

(2009) Xiongying Yuan et al.   BMC Systems Biology

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

MicroRNAs and the kidney: coming of age

(2009) Samuel Saal et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

(2009) Monika Jung et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNAs in clinical oncology: at the crossroads between promises and problems

(2009) S M Metias et al.   JOURNAL OF CLINICAL PATHOLOGY

Small but influential: the role of microRNAs on gene regulatory network and 3′UTR evolution

(2009) Rui Zhang et al.   Journal of Genetics and Genomics

The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma

(2009) Tsz-fung F. Chow et al.   JOURNAL OF UROLOGY

Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell

(2009) G. Sotiropoulou et al.   RNA

p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest

(2008) C. J. Braun et al.   CANCER RESEARCH

Rising incidence of renal cell carcinoma in Ireland

(2008) Opeyemi A. Falebita et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY